Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Mr. Jason B. Shandell has stepped down as President, General Counsel, and member of the Board of Directors, effective April 10, 2020. Mr. Shandell and the Company have mutually agreed that now is the
RANCHO CUCAMONGA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a...

Needham Remains a Hold on BioCryst (BCRX)

09:55am, Monday, 13'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX). The company's shares closed last Thursday at $2.07,

Needham Remains a Hold on BioCryst (BCRX)

09:55am, Monday, 13'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX – Research Report). The
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI) and Neurocrine (NBIX) with bullish
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma ( AERI – Research Report ) and Neurocrine ( NBIX – Research Report ) with bullish sent
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, Apr
RANCHO CUCAMONGA, April 09, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and...
AQR Capital Management LLC lessened its stake in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Com
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA) today and set a price target of $30.00. The company's shares closed
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) today and set a price
Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV) today and set a price target of $28.00. The company's shares
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE